ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 1560 in its research report dated October 15, 2025.
ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 1000 in its research report dated April 24, 2025.
ICICI Securities is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 825 in its research report dated July 24, 2024.
ICICI Securities is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 750 in its research report dated May 15, 2024.
ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.
Going forward, technology will be the differentiator, and Vijay Diagnostic's differentiated hub- and-spoke model calls for attention
The key strength of Vijaya Diagnostic lies in its heavy B2C mix – more than 90 per cent of business flows from individual customers. This ensures that the company has almost negligible receivables which helps it to maintain a negative working capital.
The key differentiator in the business model of Krsnaa Diagnostics is the hub-and-spoke model in radiology
Prabhudas Lilladher is bearish on Thyrocare Technologies has recommended sell rating on the stock with a target price of Rs 307 in its research report dated August 04, 2020.
Prabhudas Lilladher is bearish on Thyrocare Technologies has recommended sell rating on the stock with a target price of Rs 307 in its research report dated May 27, 2020.
Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 686 in its research report dated November 08, 2019.
Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 595 in its research report dated August 14, 2019.
Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated February 12, 2019.
Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 796 in its research report dated November 12, 2018.
Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated August 14, 2018.
Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated August 06, 2018.
Edelweiss is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 750 in its research report dated May 03, 2018.
Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated May 04, 2018.
Edelweiss is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 12, 2017.
Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 1067 in its research report dated November 17, 2016.